Description

Eprazinone is a synthetic organic compound with significant pharmacological activity, primarily functioning as an expectorant and mucolytic agent. Its importance lies in its ability to effectively reduce the viscosity of bronchial secretions, facilitating airway clearance and improving respiratory function. This makes it a critical active pharmaceutical ingredient (API) for manufacturers developing prescription and over-the-counter cough and cold medications. Industries requiring this compound include the pharmaceutical sector for drug formulation and research & development laboratories exploring new therapeutic applications.

Application

• Primary Pharmaceutical Ingredient: Core active component in formulated expectorant and mucolytic drugs for treating acute and chronic bronchitis.
• Respiratory Medication Formulation: Used in the production of syrups, tablets, and capsules aimed at alleviating symptoms of productive cough and bronchial congestion.
• Veterinary Pharmaceutical Applications: Incorporated into medicinal products for treating respiratory conditions in animals.
• Reference Standard: Serves as a high-purity analytical standard for quality control and regulatory testing in pharmaceutical laboratories.
• Research & Development: Utilized in preclinical and clinical studies to investigate new indications or improved drug delivery systems for respiratory therapies.
• Generic Drug Manufacturing: Essential for companies producing bioequivalent versions of branded expectorant medications.

Basic Information

Product Name	Eprazinone
CAS No.	10402-90-1
Molecular Formula	C₂₄H₃₂N₂O₂
Molecular Weight	380.53 g/mol
Synonyms	Eprazinone; Eftapan; Muctium; Resplen; 3-[4-(2-Ethoxy-2-phenylethyl)-1-piperazinyl]-2-methyl-1-phenyl-1-propanone; 1-Phenyl-2-methyl-3-[4-(2-phenoxyethyl)-1-piperazinyl]-1-propanone; α-Methyl-α-phenyl-β-[4-(β-phenoxyethyl)-1-piperazinyl]propionphenone
EINECS	233-881-5

Quality Control

Our Eprazinone is manufactured under strict quality management systems, ensuring it meets the stringent requirements for pharmaceutical intermediates and active ingredients. Each batch is subjected to comprehensive analytical testing, including identity confirmation, purity assay, and impurity profiling via advanced techniques like HPLC and GC. We provide full traceability and support regulatory submissions with comprehensive documentation. Certificates of Analysis (COA) detailing all test results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed when not in use to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.5%
Related Substances (HPLC)	Total impurities ≤ 1.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.